The Evolution of Drug Resistance inMycobacterium tuberculosis:From a Mono–Rifampin‐Resistant Cluster into Increasingly Multidrug‐Resistant Variants in an HIV‐Seropositive Population-Reference-Cited by-同舟云学术

The Evolution of Drug Resistance inMycobacterium tuberculosis:From a Mono–Rifampin‐Resistant Cluster into Increasingly Multidrug‐Resistant Variants in an HIV‐Seropositive Population

Published:2008-07 Issue:1 Volume:198 Page:90-94
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Bifani Pablo,Mathema Barun,Kurepina Natalia,Shashkina Elena,Bertout Julie,Blanchis Anne Sophie,Moghazeh Soraya,Driscoll Jeffrey,Gicquel Brigitte,Frothingham Richard,Kreiswirth Barry N.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/198/1/90/18053896/198-1-90.pdf

Reference15 articles.

1. Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis

2. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS.

3. Rifampin‐Monoresistant Tuberculosis in New York City, 1993–1994

4. Tuberculosis Drug Serum Levels

5. The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in the Use of Proper Methods for Estimating Mutation Rates in Fluctuation Experiments;Axioms;2023-12-01

2. Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis;Frontiers in Cellular and Infection Microbiology;2022-08-22

3. Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens;Clinical Microbiology and Infection;2020-10

4. Aspectos associados à drogarresistência em pessoas com Tuberculose/HIV: revisão integrativa;Acta Paulista de Enfermagem;2020

5. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis;BMJ Open;2019-11